UBS/CALL/ABBOTT LABORATORIES/125/0.1/20.12.24 Stock

Warrant

CH1227466997

Market Closed - Deutsche Boerse AG 01:41:41 2024-07-12 pm EDT
0.103 EUR -7.21% Intraday chart for UBS/CALL/ABBOTT LABORATORIES/125/0.1/20.12.24
Current month+37.33%
1 month-14.17%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.103 -7.21%
24-07-11 0.111 +26.14%
24-07-10 0.088 +87.23%
24-07-09 0.047 -18.97%
24-07-08 0.058 -7.94%

Delayed Quote Deutsche Boerse AG

Last update July 12, 2024 at 01:41 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer UBS
WKN UL11GQ
ISINCH1227466997
Date issued 2023-02-21
Strike 125 $
Maturity 2024-12-20 (161 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.9
Lowest since issue 0.034
Spread 0.01
Spread %9.09%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.2 USD
Average target price
124.8 USD
Spread / Average Target
+19.72%
Consensus